These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)]. Pawelski S Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218 [TBL] [Abstract][Full Text] [Related]
5. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine. Schirmer M; Haun M; Grünewald K; Geisen F; Hilbe W; Thaler J; Konwalinka G Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455 [TBL] [Abstract][Full Text] [Related]
6. Development of cladribine at Scripps for hairy cell leukemia and current results. Torrey ML; Sigal DS; Saven A Leuk Lymphoma; 2011 Jun; 52 Suppl 2():29-33. PubMed ID: 21504293 [TBL] [Abstract][Full Text] [Related]
9. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment]. Urasiński I; Zdziarska B; Krygier-Stojałowska A Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443 [TBL] [Abstract][Full Text] [Related]
10. Cladribine in hairy cell leukemia. Belani R; Saven A Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111 [TBL] [Abstract][Full Text] [Related]
11. [Complete remission in a patient with hairy cell leukemia after treatment with 2-chlorodeoxyadenosine]. Komarnicki M; Kaźmierczak M Acta Haematol Pol; 1993; 24(1):77-81. PubMed ID: 8098177 [No Abstract] [Full Text] [Related]
12. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Zenhäusern R; Simcock M; Gratwohl A; Hess U; Bargetzi M; Tobler A; Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561 [No Abstract] [Full Text] [Related]
14. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases. Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472 [No Abstract] [Full Text] [Related]
15. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
16. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia. Dedic K; Zák P Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661 [TBL] [Abstract][Full Text] [Related]
17. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Rai KR Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325 [TBL] [Abstract][Full Text] [Related]
18. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Robak T; Błasińska-Morawiec M; Krykowski E Acta Haematol Pol; 1992; 23(4):285-90. PubMed ID: 1363455 [TBL] [Abstract][Full Text] [Related]